Foothill Ventures

Foothill Ventures is a venture capital investment firm based in Los Altos, California, that focuses on seed-stage and early-stage technology companies. Founded in 2011, it primarily invests in a diverse range of sectors, including healthcare, information technology, cybersecurity, big data, robotics, life sciences, and various emerging technologies such as artificial intelligence and blockchain. The firm aims to support innovative startups in the United States, leveraging its expertise to help them grow and succeed in competitive markets. As a Registered Investment Adviser, Foothill Ventures is committed to identifying and nurturing promising technology-driven ventures.

Biao He

Venture Partner

Michael Jin

Managing Partner and Co-Founder

Eric Rosenblum

Venture Partner

Xuhui Shao

Managing Partner

Sophia Yu

Investment Associate

Past deals in Nanotechnology

Coreshell

Series A in 2025
Coreshell Technologies, Inc. is a company focused on developing advanced lithium-ion batteries, primarily targeting the electric vehicle and grid storage markets. Founded in 2017 and based in Berkeley, California, Coreshell has pioneered a nanolayer thin-film coating technology that addresses the degradation issues commonly faced by rechargeable batteries. This innovative coating protects battery electrodes from chemical reactions that can diminish capacity and safety, thereby enhancing the overall performance and durability of the batteries. By seamlessly integrating into existing manufacturing processes, Coreshell's technology aims to significantly improve battery capacity, safety, and cost-effectiveness, facilitating a smoother transition to electric transportation and renewable energy solutions.

NovoLINC

Seed Round in 2025
NovoLINC is a pioneering startup that provides thermal interface solutions. It develops a distinctive system of nanostructured materials and a proprietary manufacturing process with the objective of transforming thermal management.

Coreshell

Series A in 2022
Coreshell Technologies, Inc. is a company focused on developing advanced lithium-ion batteries, primarily targeting the electric vehicle and grid storage markets. Founded in 2017 and based in Berkeley, California, Coreshell has pioneered a nanolayer thin-film coating technology that addresses the degradation issues commonly faced by rechargeable batteries. This innovative coating protects battery electrodes from chemical reactions that can diminish capacity and safety, thereby enhancing the overall performance and durability of the batteries. By seamlessly integrating into existing manufacturing processes, Coreshell's technology aims to significantly improve battery capacity, safety, and cost-effectiveness, facilitating a smoother transition to electric transportation and renewable energy solutions.

Coreshell

Seed Round in 2020
Coreshell Technologies, Inc. is a company focused on developing advanced lithium-ion batteries, primarily targeting the electric vehicle and grid storage markets. Founded in 2017 and based in Berkeley, California, Coreshell has pioneered a nanolayer thin-film coating technology that addresses the degradation issues commonly faced by rechargeable batteries. This innovative coating protects battery electrodes from chemical reactions that can diminish capacity and safety, thereby enhancing the overall performance and durability of the batteries. By seamlessly integrating into existing manufacturing processes, Coreshell's technology aims to significantly improve battery capacity, safety, and cost-effectiveness, facilitating a smoother transition to electric transportation and renewable energy solutions.

Quantapore

Series C in 2018
Quantapore Inc. is a biotechnology company established in 2009 and headquartered in Menlo Park, California, focused on developing nanopore-based nucleic acid sequencing technology. The company's innovative approach employs an optical readout system, which differentiates it from other nanopore methods that typically rely on electrical data acquisition. This technology facilitates rapid and cost-effective sequencing of DNA by utilizing a proprietary optically labeled nanopore that interacts with labeled nucleic acid samples through energy transfer. This quantum-optic interaction enables single molecule sequencing, allowing for high throughput and sensitivity. Quantapore's advancements in sequencing technology aim to enhance medical diagnostics and contribute to improvements in human health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.